Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. There are several important ...

The study covered in this summary was published on ssrn.com as a preprint and has not yet been peer reviewed. Cytarabine plus an anthracycline has been the standard AML induction regimen for decades, ...

A research team from the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong ...

SAN DIEGO -- Autologous stem-cell transplantation (ASCT) led to improved outcomes as compared with CAR T-cell therapy for patients with relapsed large B-cell lymphoma (LBCL) in complete remission, a ...

Please provide your email address to receive an email when new articles are posted on . Treatment with CTX130, a novel chimeric antigen receptor T-cell therapy, led to disease control in more than ...

(Gray News) - Rectal cancer patients with a particular kind of mutation are reporting positive results after receiving a new therapy called dostarlimab. According to the New England Journal of ...

A newly developed targeted radiopharmaceutical treatment can effectively slow tumor growth in pancreatic ductal ...

Remission rates for ovarian cancer patients remained stable before and after the COVID-19 pandemic, despite treatment delays and protocol changes. The study involved 748 patients, with no significant ...

SEATTLE, WA / ACCESSWIRE / November 3, 2020 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its ...

IN8bio, Inc. announced that 100% of acute myeloid leukemia (AML) patients treated with its allogeneic gamma-delta T cell therapy, INB-100, remain in complete remission (CR) with a median follow-up of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Complete remission at 8 weeks was observed in patients ...